L. Alison McInnes, MD, MS

Medical Director
Dr. McInnes is a nationally recognized expert in psychiatry, mood and anxiety disorders, ketamine treatment, and psychedelic medicine. She founded and served as Medical Director for Kaiser Permanente's ketamine infusion therapy program for a number of years. She was previously an Associate Professor of Psychiatry at Mount Sinai School of Medicine for 8 years where she ran a lab in psychiatric genetics, and is currently an adjunct clinical professor at UCSF.

Dr. McInnes is additionally a member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) Certification Governance Commission, which is an autonomous governing body that oversees the development, implementation, and management of a certification program for clinicians offering ketamine therapy. In her current clinical practice, she focuses on ketamine infusion therapy and ketamine-assisted psychotherapy for treatment-resistant mood disorders and complex cases. She has extensive experience with ketamine infusion therapy at some of the earliest and most successful ketamine therapy clinics.

Dr. McInnes received Bachelor’s and Master’s degrees from Stanford University and her MD from Columbia University. She completed residency at UCSF and research at the VA Research Fellowship and Howard Hughes Physician Research Fellowship in Psychiatric Genetics at UCSF.